Ocular Therapeutix Stock Forecast for 2023 - 2025 - 2030
Updated on 05/01/2024
Ocular Therapeutix Stock Forecast and Price Target
The average price target for Ocular Therapeutix's stock of $15.00 recently provided by three leading analysts would represent a 198.8% upside from its last closing price if reached. This potential increase is based on a high estimate of $24.00 and a low estimate of $11.00. Even if you are not interested in OCUL stock, you should still be aware of its competitors.
198.80% Upside
Ocular Therapeutix Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Ocular Therapeutix's Price has grown from $0.00 to $0.00 – a 100.00% increase. Next year, analysts are expecting Fair Value to reach $5.39 – an increase of 100.00%. Over the next seven years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| GKOS Stock Forecast | Glaukos | Outperform |
7
|
$98.91 | Buy/Sell | $87.33 | 9.19% |
| TNE Stock Forecast | Technology One | Hold |
16
|
$16.00 | Buy/Sell | $16.29 | 3.13% |
| BHC Stock Forecast | Bausch Health Companies | Hold |
15
|
$8.75 | Buy/Sell | $9.50 | 8.57% |
| FAGR Stock Forecast | Fagron NV | Buy |
18
|
18.24€ | Buy/Sell | 20.38€ | 20.61% |
| HROW Stock Forecast | Harrow | Buy |
12
|
$10.43 | Buy/Sell | $28.13 | 158.87% |
Ocular Therapeutix Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Ocular Therapeutix's Revenue has grown from $17.40M to $58.44M – a 235.86% increase. Next year, analysts are expecting Revenue to reach $76.93M – an increase of 31.64%. Over the next seven years, the forecast is for Revenue to grow by 1167.09%.
.jpg)
Ocular Therapeutix EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Ocular Therapeutix's EBITDA has grown, rising from $-60.07M to $-79.40M – a growth of 32.18%. In the following year, 2 experts forecast that Ocular Therapeutix's EBITDA will decrease by 62.70%, to $-29.62M. In 2030, professionals predict that Ocular Therapeutix's EBITDA will decrease by 379.65%, to $222.04M.
Ocular Therapeutix EBIT Forecast for 2023 - 2025 - 2030
Ocular Therapeutix's EBIT has grown In the last three years, rising from $-62.85M to $-82.38M – a growth of 31.07%. 8 analysts predict Ocular Therapeutix's EBIT will decrease by 6.11% in the next year, reaching $-77.35M. By 2030, professionals predict that Ocular Therapeutix's EBIT will decrease by 355.22%, to $210.25M.
Ocular Therapeutix EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Ocular Therapeutix's EPS has grown from $-1.14 to $0.00 – a 100.00% increase. Next year, analysts are expecting EPS to reach $-0.60 – an increase of 100.00%. Over the next seven years, the forecast is for EPS to grow by 100.00%.
.jpg)